- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 513/10
Total number of patents in this class: 217
10-year publication summary
|
13
|
10
|
15
|
16
|
24
|
13
|
18
|
20
|
11
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4427 |
36 |
| Pfizer Inc. | 3386 |
10 |
| Merck Sharp & Dohme LLC | 3734 |
9 |
| Janssen Pharmaceutica N.V. | 3168 |
8 |
| Gilead Sciences, Inc. | 2222 |
8 |
| Genentech, Inc. | 4104 |
6 |
| Array BioPharma Inc. | 446 |
6 |
| Merck Patent GmbH | 5728 |
5 |
| NSC Therapeutics GmbH | 8 |
5 |
| VALO Health, Inc. | 193 |
5 |
| Betta Pharmaceuticals Co., Ltd. | 179 |
4 |
| Israel Institute for Biological Research | 5 |
4 |
| Jacobio Pharmaceuticals Co., Ltd. | 104 |
4 |
| F. Hoffmann-La Roche AG | 7837 |
3 |
| Chronos Therapeutics Limited | 19 |
3 |
| Jazz Pharmaceuticals Ireland Limited | 172 |
3 |
| Katholieke Universiteit Leuven | 1283 |
3 |
| Aligos Therapeutics, Inc. | 163 |
3 |
| Kanaph Therapeutics Inc. | 44 |
3 |
| Beijing Greatway Pharmaceutical Technology Co., Ltd. | 6 |
3 |
| Other owners | 86 |